Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists

• Main Authors: Elnaem, Mohamed Hassan Abdelaziz, Cheema, Ejaz
• Format: Article
• Language: English; English
• Published: Elsevier 2020
• Subjects: RC648 Specialties of Internal Medicine-Diseases of The Endocrine Glands. Clinical Endocrinology; RM283 Endocrinotheraphy; RM300 Drugs and their action
• Online Access: http://irep.iium.edu.my/80703/7/80703%20Caring%20for%20patients%20with%20diabetes%20during%20COVID-19%20pandemic%20-In-press.pdf; http://irep.iium.edu.my/80703/8/80703%20Caring%20for%20patients%20with%20diabetes%20during%20COVID-19%20pandemic%20%20SCOPUS%20In-press.pdf; http://irep.iium.edu.my/80703/; https://www.sciencedirect.com/science/article/pii/S1551741120306537; https://doi.org/10.1016/j.sapharm.2020.05.030

The current pandemic of the COVID-19 infection, coupled with the increased global burden of diabetes, has imposed significant challenges to the healthcare providers in providing effective and sustained care to patients with diabetes during the ongoing pandemic. It is, therefore, important for healthcare providers to understand and follow the recommended changes in the delivery of care, lifestyle modifications, and pharmacotherapy to ensure optimal care to the patients during and post-pandemic era. This commentary aims to discuss the impact of COVID-19 on diabetes care and the important considerations for pharmacists during this pandemic.